NEW YORK (AP) -- Invitrogen Corp. and Applied Biosystems Inc. said late Wednesday they plan to reorganize their businesses into four units following their combination this fall.
Invitrogen agreed to buy Applied Biosystems for $6.4 billion in June, uniting two companies that work on medical research tools. The combined company will be called Applied Biosystems.
The companies said their merged business will consist of four divisions: molecular biology systems, genetic systems, cell systems and mass spectrometry systems. They also provided more details about their planned leadership structure.
Carlsbad, Calif.-based Invitrogen and Foster City, Calif.-based Applied had already said Invitrogen Chief Executive Greg Lucier will lead the combined company, and Applied Biosystems' Chief Operating Officer Mark Stevenson will keep the same position.
On Wednesday the companies said their chief financial officer will be David Hoffmeister, Invitrogen's CFO.
They also named Bernd Brust as the leader of Global Commercial Operations, while Peter Leddy will lead Global Human Resources and Mark O'Donnell will be head of Global Operations and Services. Brust and Leddy are currently with Invitrogen, while O'Donnell works at Applied Biosystems.
Applied Biosystems was a unit of Applera. The deal is still pending approval by shareholders and regulators.